🔎 Trials Near Me

Hjem › Burkitts lymfom › Iowa

Burkitts lymfom kliniske forsøg i Iowa

7 studier for Burkitts lymfom søger deltagere på steder i Iowa.

Byer i Iowa

Officiel studietekst (engelsk)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Blank Children's Hospital, Des Moines
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
RekruttererFase 2
366 Days – 46 Years · Alle køn · Opdateret 2. okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
RekruttererFase 3
Alder 18 til 39 · Alle køn · Opdateret 2. okt. 2026 · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • University of Iowa-Holden Comprehensive Cancer Center ( Site 1017), Iowa City
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Blank Children's Hospital, Des Moines
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
RekruttererFase 2
Alder 1 til 30 · Alle køn · Opdateret 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Blank Children's Hospital, Des Moines
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
RekruttererFase 3
365 Days – 25 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03959085

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

  • Research Site, Iowa City
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT07109219

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.